Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency

INTRODUCTION: Continuous infusion (CI) of clotting factors as a replacement therapy for perioperative hemostatic protection has been performed for many years, including with factors VIII and IX and recombinant activated factor VII (rFVIIa). This approach provides steady factor levels without requiri...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajpurkar, Madhvi, Cooper, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276614/
https://www.ncbi.nlm.nih.gov/pubmed/30568523
http://dx.doi.org/10.2147/JBM.S184040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276614/
https://www.ncbi.nlm.nih.gov/pubmed/30568523
http://dx.doi.org/10.2147/JBM.S184040

Ejemplares similares